For many years rats have been considered highly resistant to tuberculosis and, by implication, unsuitable for studies in experimental tuberculosis. Early workers had established that rats survived infection with doses of virulent tubercle bacilli many times higher than those which kill guinea pigs (8, 14, 22) . These investigators were unable to elicit tuberculin hypersensitivity in tuberculous rats. Subsequently, Wessels (28) demonstrated the growth of virulent tubercle bacilli in the organs of rats, which also developed delayed hypersensitivity to tuberculin. These results were confirmed by Gray et al. (11) , who suggested that rats are no less susceptible to tuberculosis than are some strains of mice. Since then, delayed hypersensitivity to other antigens has also been induced in rats (5) .
Despite the latter findings, rats have been little used in tuberculosis research and, in a recent analysis of experimental models for the study of immunity in tuberculosis, rats were not even considered (30) . Yet rats have potential advantages over other species in the study of immune mechanisms: the physiology of their lymphocytes has been characterized most extensively and the thoracic duct which discharges relatively pure populations of lymphocytes can be cannulated with comparative ease (4, 7, 12) . It was therefore decided to initiate a study of tuberculosis in rats to see whether these advantages could be exploited to characterize the cells responsible for antibacterial immunity.
MATERIALS AND METHODS
Animals. Female (Lewis x BN)F, rats were used.
Cell donors were 8 to 12 weeks old, 150 to 200 g in weight. Recipient rats were 5 weeks old and 80 to 100 g in weight.
Cultures. Strains of mycobacteria were obtained from the Trudeau Mycobacterial Culture Collection, Trudeau Institute, Saranac Lake, N.Y. Two attenuated strains, BCG Copenhagen (TMC 1010) and RlRv (TMC 205) , and one virulent strain, H37Rv (TMC 102), were used. All mycobacterial cultures were maintained by serial passage in Middlebrook 7H9 broth (Difco Laboratories, Detroit, Mich.). Cultures were used after 5 to 8 days of incubation at 37 C.
A virulent strain of Listeria monocytogenes was stored in liquid nitrogen (15) , from which it was recovered as required.
Immunization. A culture of mycobacteria was washed four times in saline containing 0.05% Tween 80 (polyethylene sorbitan monooleate; BBL) by centrifugation at 5650 x g for 20 min. The culture was reconstituted to its original volume in Tween-saline and briefly ultrasonicated to disperse clumps. Rats were immunized by injecting 0.1-ml samples of bacterial suspension into eight sites distributed over the 182 RAT IMMUNITY TO hindquarters: into each footpad, subcutaneously into the medial aspect of each leg, subcutaneously into each groin. There was a single subcutaneous injection into the base of the tail and a single intraperitoneal injection. The immunization technique was based upon that described by Delorme and others (3).
L. monocytogenes was diluted to a density of 2.5 x 107 viable bacteria/ml and 0.1-ml samples were injected into each footpad, a total animal dose of 5 x 106 organisms. The following day a fresh Listeria suspension of 2.5 x 107 viable bacteria/ml was made, and 0.1-ml aliquots were injected subcutaneously into the base of the tail and at three lower abdominal sites, a total animal dose of 107 organisms.
Challenge. For growth curve data or challenge of cell recipients, an unwashed mycobacterial culture was briefly sonicated, and a total bacterial count was made in a Petroff-Hausser counting chamber. The culture was diluted, as necessary, in sterile saline, and 1-ml samples were injected intravenously. L. monocytogenes cultures were appropriately diluted in saline and 1 ml was injected intravenously into each rat.
Viable counts. Viable counts of bacteria were made from inoculum suspensions and from liver and spleen homogenates. Mycobacteria were grown on Middlebrook 7H10 agar plates (Difco), which were incubated at 37 C for 3 weeks. L. monocytogenes was grown on tryptic-soy agar plates (BBL, Cockeysville, Md.), which were incubated at 37 C overnight. Five rats from each experimental group were killed at each time point, and the geometric mean viable count per group was determined. Analysis of variance was used to evaluate the experimental data.
Cell transfer. Lymphocytes obtained from the thoracic duct of donor rats were collected during the first 24 h of lymph drainage. The cells were counted, centrifuged from the lymph, and resuspended at a cell density of 108/ml in Hanks basal salt solution containing 1% fetal calf serum. In all experiments, the thoracic duct lymphocytes (TDL) were injected intravenously.
Immune serum. Rats were immunized with BCG as described above. On the eighth day of infection the rats were bled from the throat, and the serum was allowed to separate. The serum was sterilized by membrane filtration and stored at -70 C. The serum was not inactivated by heat before use. (Table 4) . Even so, the immunity conferred by 4 x 107 cells was highly significant (P < 0.01).
RESULTS

Growth of
As noted previously, even the largest cell dose conferred little protection on the liver.
Adoptive immunity against a virulent challenge. TDL obtained from donor rats on the eighth day of an immunizing BCG infection were transferred into recipient rats. The cells, in a dose equal to 2 x 108/100 g, were injected 1 h after the recipients had been infected with either 3 x 104 RlRv or 3 x 104 H37Rv. Viable counts of mycobacteria in the livers and spleens of these adoptively immunized animals and groups of nonimmunized controls were made 14 days after challenge ( Table 5 ). The counts of H37Rv were higher than those of RlRv in livers and spleens of both normal and adoptively immunized subjects, a reflection of the virulence of the former strain. Adoptively immunized rats inhibited the growth of both organisms to a similar extent: the levels of protection in the spleens were 1.39 and 1.21 log U for RlRv and H37Rv, respectively. Once again, protection in the liver was minimal.
Specificity of the adoptive immune response. The specificity of the immunity transferred with TDL was tested reciprocally: cells from Listeria and BCG immunized rats being measured for protective activity against both RlRv and L. monocytogenes. TDL were collected 6 days after donor rats had been immunized with L. monocytogenes, and 2 x 108 TDL were injected into recipients who had been challenged intravenously with either 106 L. monocytogenes or 7 x 104 RlRv (Table 6 ). Appropriate control rats did not receive cells. Viable counts of L. monocytogenes and RlRv were made from the liver and spleen 48 h and 14 days after challenge, respectively. The immunity conferred adoptively was specific to L. monocytogenes, there being no evidence of cross-protection against M. tuberculosis RlRv.
In looking at the opposing situation, account was taken of the fact that BCG provokes a substantial level of nonspecific, macrophagemediated resistance (2) . It is known that nonspecific resistance is caused by the action of antigen upon specifically sensitized lymphocytes (18) . To provoke this reaction, the dose of RlRv used to challenge the adoptively immunized rats and their controls was deliberately increased to 5 x 106.
Groups of recipient rats were infected intravenously with either 5 x 104 RlRv, 106 L. monocytogenes, or both organisms. Half of the rats in each group were given TDL obtained on the eighth day of a BCG infection; the remaining rats received no cells. Protection conferred by TDL was specific (Table 7) : the recipients of TDL inhibited the growth of RlRv (rows 1 and 2), but not the growth of L. monocytogenes (rows 3 and 4). In addition, the experiment reveals that rats whch had been adoptively sensitized to RlRv also developed a significant measure (P < 0.01) of nonspecific resistance to L. monocytogenes only when the cell recipients were challenged simultaneously with RlRv insubstantial evidence, derived mainly from the study of Ornstein and Steinbach (22), who infected rats with a large dose of virulent tubercle bacilli which failed to kill the host, render it sensitive to tuberculin, or produce the typical lesions of tuberculosis. Of these findings, only the resistance of rats to the lethal effects of tuberculosis has been adequately substantiated. Many investigators have described the formation of noncaseating tubercles in rats (8, 14, 16) , and Hehre and Freund (14) observed systemic tuberculin sensitivity but no dermal sensitivity. Subsequently, Wessels (29, 30) found that tubercle bacilli could grow in the organs of rats and cause delayed-type tuberculin hypersensitivity. These findings have been amply confirmed more recently (10, 11) . Despite this evidence, the original notion persists that rats are naturally resistant to tuberculosis and hence unsuitable for the study of immunity in this infection. In the present study it was shown that the virulent strain H37Rv and the attenuated strain RlRv can grow in the liver and spleen of intravenously infected rats. Although data have not been presented, the even more attenuated strain BCG multiplied in the same organs. These observations have been confirmed in Lewis rats and members of the (Lewis x DA)F, cross, supporting the proposition of Gray (10) that the growth of tubercle bacilli in rats is comparable with that in mice.
After infection with 107 to 108 BCG or RlRv, rats rapidly develop a state of acquired immunity to tuberculosis. As early as 4 days after infection, TDL were capable of conferring specific resistance upon normal syngeneic recipients, and maximum immunity was conveyed by cells obtained 6 to 10 days after infection ( Table  1) . As a consequence of the extremely rapid production of cells with protective activity, large inocula of tubercle bacilli do not grow, thus giving a spurious appearance of natural resistance in this host species (15) . In truth, the apparent natural resistance of the rat is due to rapid induction of acquired immunity, as inferred by previous investigators (23, 24) .
Adoptive immunity to tuberculosis has been achieved in rabbits (6, 17) , guinea pigs (26) , and mice (20, 25) . With the exception of Sever (25), all these investigators used randomly bred animals in which the inevitable reactions of histocompatibility would raise resistance nonspecifically (1) and call in question the significance of the effects observed. In addition, mixed populations of lymphoid cells (lymph node, spleen, or peritoneal exudate cells) have been used in all previous studies. These cell populations included macrophages, which some investigators construed to be the cell type predominantly involved in the transfer of immunity (6, 20, 25) . It is significant, therefore, that in the present investigation immunity was transferred by lymphocytes obtained from the thoracic duct. Immunity acquired in this manner was clearly mediated by living donor cells, for it was related to the number transferred and the level of resistance in the donors. Moreover, heatkilled cells or serum from immune donors conveyed no protection whatsoever.
Cellular events underlying the development of immunity to the tubercle bacillus cannot readily be analyzed in the infected animal because the response to infection involves not only the production of specifically sensitized lymphocytes but also secondary changes in macrophages, the cells through which resistance to infection is ultimately expressed. It is to be noted in this connection that the macrophages of tuberculous animals acquire an enhanced microbicidal capability which is nonspecific, because it is expressed against a variety of bacterial cell targets; but the participation of specifically sensitized lymphocytes is an essential requirement for the development of activated macrophages (19) . This was again illustrated in the present study by the specificity of the immunity transfered with lymphocytes. TDL from Listeria-infected rats protected against L. monocytogenes but not against 188 LEFFORD, MCGREGOR, AND MACKANESS RlRv, and vice versa.
The rats which were infected with RlRv and superinfected with L. monocytogenes are of particular interest. Animals which received only the TDL from BCG-sensitized donors or were infected with RlRv without receiving cells were fully susceptible to L. monocytogenes; but those which received TDL from BCG-immunized rats and were also challenged with RlRv showed a small but significant level of resistance to L. monocytogenes. This phenomenon is analogous to the rapid recall of nonspecific resistance which is observed when BCG-immunized mice are reinfected with the homologous organism (2) . It occurs also in mice challenged with BCG after adoptive sensitization with spleen cells from BCG-immunized donors (18) .
A constant but unexplained feature of this investigation was the difference between actively and adoptively immunized rats in the expression of immunity in the liver and spleen. Immunity to reinfection was expressed in both organs, whereas the immunity transferred by TDL from specifically immunized donors was expressed only in the spleen (Table 4 and Fig.  2 ). The apparent defect in the expression of antimicrobial resistance in the livers of adoptively immunized rats is much less apparent in rats adoptively immunized against listeria and is not observed in animals actively infected with BCG (Fig. 2) . Immunity in the latter represents the summation of two effector mechanisms. One is mediated by macrophages, which are already activated at the time of reinfection, and a second is mediated by specifically sensitized lymphocytes which respond to the reinfecting organisms. Because Kupffer cells in the liver become integrated into developing tubercles (R. J. North, unpublished data), the tubercles formed in reinfected animals would be composed from the outset of highly activated phagocytes, whereas those formed in adoptively immunized animals under the influence of specifically sensitized lymphocytes would be constructed of circulating monocytes and nonactivated Kupffer cells (21) . Clearly, the reinfected animals would have an advantage.
Although this explanation may account for the difference between active and adoptive immunity as expressed in the liver, it does not explain why a difference should exist between spleen and liver in the adoptively immunized rat. The failure to express adoptive immunity is not peculiar to the liver, however, for an even greater defect has been found in the ability of the adoptively immunized mouse to defend the lung against an aerogenic infection with L. monocytogenes (27) . A possible reason for this phenomenon is the sequestration in the spleen INFECT. IMMUNITY and lymph nodes of intravenously injected lymphocytes obtained either from normal (9, 13) (Table  6) , and raises an alternative possibility based upon a difference in the composition of the specifically sensitized lymphocyte populations used to transfer resistance to listeria and tuberculosis. It could be that TDL are a selected population which is not representative of the cells available for the defences of the intact animal. This question has been investigated in a study dealing with the properties of the lymphocytes which mediate host resistance to the tubercle bacillus (M. J. Lefford, D. D. McGregor, and G. B. Mackaness, Immunology, in press).
